Référentiel des médicaments
Valoctocogene roxaparvovec
Valoctocogene roxaparvovec is a medicine in the class miscellaneous. It is used for hemophilia a.
- Classe médicamenteuse: Miscellaneous
- Indications: hemophilia a
Dernière mise à jour Sources: EMA SmPC
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Miscellaneous
- Code ATC
- B02BD15
- Interactions connues
- 40 (Majeure: 6 · Modérée: 33 · Mineure: 1)
- Noms commerciaux
- 1
- Pays et marchés
- 1
Indications
Mécanisme d'action
AAV5-based gene therapy vector that expresses B-domain deleted SQ recombinant human factor VIII (hFVIII-SQ) under a liver-specific promoter, replacing the missing factor VIII. Vector DNA forms episomal transgenes that support long-term hFVIII-SQ production.
Posologie adulte habituelle (résumé de la notice)
Severe haemophilia A: 6 × 1013 vg/kg body weight, intravenous, as a single infusion. Dose volume in mL = body weight in kg multiplied by 3.
Grossesse et allaitement
- Grossesse
- Unsafe Gene therapy for men with severe haemophilia A. No pregnancy data or animal studies; theoretical risk of vector DNA reaching fetal cells. EU label: should not be used in pregnancy; not recommended in women who could become pregnant. Partners of treated men: double-barrier contraception for 6 months.
- Allaitement
- Unknown Not known if the vector or factor VIII it produces passes into milk; no LactMed record. EU label: a risk to the infant cannot be excluded; should not be used while breastfeeding. It is licensed for men, so use while breastfeeding is not expected.
Effets indésirables signalés
- ALT increased
- AST increased
- LDH increased
- CPK increased
- Nausea
- Headache
Contre-indications
- Hypersensitivity to the active substance or any excipient.
- Active infections (acute or uncontrolled chronic), or known significant hepatic fibrosis or cirrhosis.
Précautions particulières
- Only for patients demonstrated to lack anti-AAV5 antibodies by a validated assay; not indicated with a history of factor VIII inhibitors.
- Hepatic reactions (ALT increase) occur in most patients; monitor ALT and factor VIII activity and give corticosteroids as needed.
- Infusion-related reactions can occur; monitor during and after infusion.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Principales interactions (40)
- Dantrolene + Valoctocogene roxaparvovec Major
- Efavirenz + Valoctocogene roxaparvovec Major
- Flutamide + Valoctocogene roxaparvovec Major
- Nevirapine + Valoctocogene roxaparvovec Major
- Propylthiouracil + Valoctocogene roxaparvovec Major
- Valoctocogene roxaparvovec + Valproic acid Major
- Allopurinol + Valoctocogene roxaparvovec Moderate
- Amiodarone + Valoctocogene roxaparvovec Moderate
- Amoxicillin-clavulanic acid + Valoctocogene roxaparvovec Moderate
- Azathioprine + Valoctocogene roxaparvovec Moderate
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Valoctocogene roxaparvovec : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Questions fréquentes
What is Valoctocogene roxaparvovec used for?
Valoctocogene roxaparvovec is a medicine in the class miscellaneous. It is used for Hemophilia a.
What side effects have been reported with Valoctocogene roxaparvovec?
ALT increased, AST increased, LDH increased, CPK increased, Nausea, Headache.
Can Valoctocogene roxaparvovec be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Gene therapy for men with severe haemophilia A. No pregnancy data or animal studies; theoretical risk of vector DNA reaching fetal cells. EU label: should not be used in pregnancy; not recommended in women who could become pregnant. Partners of treated men: double-barrier contraception for 6 months. Breastfeeding: Unknown. Not known if the vector or factor VIII it produces passes into milk; no LactMed record. EU label: a risk to the infant cannot be excluded; should not be used while breastfeeding. It is licensed for men, so use while breastfeeding is not expected.
What does Valoctocogene roxaparvovec interact with?
MediHelp lists 40 known interactions for Valoctocogene roxaparvovec. Major: 6 · Moderate: 33 · Minor: 1. The most serious include Dantrolene, Efavirenz, Flutamide.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
